Antibiotic Prophylaxis for TEVAR

  • STATUS
    Recruiting
  • End date
    Jan 1, 2023
  • participants needed
    500
  • sponsor
    First Affiliated Hospital of Zhejiang University
Updated on 19 June 2022

Summary

The infection rate of thoracic endovascular aortic repair (TEVAR) is unknown due to a lack of epidemiological data. The rate currently available comes from researches conducted decades ago, when open surgery was the standard of care. Because of the potentially fatal consequences of a stent graft infection in the thoracic aorta, we tend to prescribe antibiotic prophylaxis for at least three days. In this study, we are going to collect data on patients receiving TEVAR in the past five years and provide the following information: a. the infection rate (MAGIC classification), b. the rate of fever, c. the results of the lab tests, such as the WBC count and C-reaction protein. d. risk factors associated with infection and fever.

Details
Condition Aortic Dissection, Aortic Diseases, Aortic Aneurysm, Thoracic, Coarctation of Aorta, Hematoma; Aorta
Treatment thoracic endovascular aortic repair
Clinical Study IdentifierNCT05405790
SponsorFirst Affiliated Hospital of Zhejiang University
Last Modified on19 June 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Diagnosed with thoracic aortic diseases
Received TEVAR

Exclusion Criteria

Suspected infectious aortic disease, such as a mycotic aneurysm
TEVAR combined with open surgery
Antibiotics have been used more than 24 hours before the operation
Combined with immune deficiency disease or using hormone or immunosuppressant;
The treatment is for the complications of TEVAR, such as endoleak
Endovascular aortic repair for abdominal aortic disease
History of open aortic surgery or heart surgery
Revascularization of visceral arteries during the TEVAR
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note